TYRA insider receives 2,925 shares in stock awards
By AlphaYouPublished Form 4
Rueb Yuliya
Reporting filer
Rueb Yuliya reported 2,925 shares of Common Stock in Tyra Biosciences, Inc. as grants or awards dated 2026-09-15. The Form 4 was disclosed on Sep 17, 2026. These were stock awards, not open-market purchases.
- Disclosed
- Sep 17, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Rueb Yuliya | 2026-09-15 | A | Grant or award | 2925 | 9.129 | 11,258 | 2 days | Filed terms
|
Common Stock
- Owner
- Rueb Yuliya
- Date
- 2026-09-15
- Code
- A
- Action
- Grant or award
- Quantity
- 2925
- Price
- 9.129
- Following holdings
- 11,258
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-15
- transaction Form Type: 5
- transaction Code: A
- equity Swap Involved: false
- id: F1
- transaction Shares: 2925
- transaction Price Per Share: 9.129
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 11258
- id: F2
- id: F3
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Rueb Yuliya: Vice President, Finance (PAO).
- F1: These shares were acquired under the Issuer's 2021 Employee Stock Purchase Plan.
- F2: Includes restricted stock units.
- F3: The previously filed Form 4 overstated the number of securities beneficially owned by the Reporting Person in column 5, due to a clerical error, which has been corrected on this Form 4.
Original sources
Prepared automatically from public filing data. Report a correction.